Wolverine Asset Management »

Nrx Pharmaceuticals shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXPW) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $993 7.7k 0.13
2023-09-30 $995 12k 0.08

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Nrx Pharmaceuticals

Wolverine Asset Management

View all funds holding Nrx Pharmaceuticals